FDA issued a Warning Letter to Nostrum Laboratories Inc on 4/27/2009 as a result of this inspection.
483 Nostrum Labs Nov 2008

483 Nostrum Labs Nov 2008

$119 - Not in Stock

FDA investigators audited the Nostrum Labs - Kansas City, MO, United States facility and issued inspectional observations (via FDA 483) on 14 Nov 2008.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Nov 2008
  • Location: Kansas City, United States
  • FEI: 1930436

Pre-Order Not Available